Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Note: Statistically significant p values are shown in boldBMD bone mineral density, TBS trabecular bone score, 25(OH)D 25-hydroxyvitamin D, PTH parathyroid hormone, ALP alkaline phosphatase, CTX C-terminal telopeptide of type 1 collagen, IGF-1 insulin-like growth factor 1, eGFR estimated glomerular filtration rateBone assessment variables in the total population (n = 112), with comparisons according to bone mineral density (BMD) and trabecular bone score (TBS) categoriesRadiological variablesTotal population (n = 112)BMDTBSNormal (n = 27)Osteopenia (n = 49)Osteoporosis (n = 36)p valueTBS > 1.31 (n = 41)TBS = 1.31 to 1.23 (n = 23)TBS < 1.23 (n = 45)p valueLumbar spine BMD, g/cm21.13 (0.97 to 1.27)1.27 [1.2 to 1.49]1.13 [1.03 to 1.27]0.93 [0.89 to 1.05] < 0.0011.19 [1.06 to 1.34]1.05 [0.91 to 1.25]1.04 [0.96 to 1.21]0.069Lumbar spine T-score, SD−0.985 (−2.08 to 0.21)0.19 [−0.44 to 2.02]−0.99 [−1.77 to 0.31]−2.59 [−2.87 to 1.66] < 0.001−0.51 [−1.39 to 0.69]−1.43 [−2.74 to 0.04]−1.57 [−2.22 to 0.12]0.07Femoral neck BMD, g/cm20.871 (0.73 to 0.95)1 [0.97 to 1.04]0.88 [0.83 to 0.9]0.7 [0.66 to 0.73] < 0.0010.88 [0.79 to 0.98]0.88 [0.73 to 0.89]0.84 [0.71 to 0.93]0.149Femoral neck T-score, SD−1.5 (−2.57 to 0.84)−0.54 [−0.72 to 0.22]−1.49 [−1.81 to 1.27]−2.83 [−3.17 to 2.59] < 0.001−1.26 [−2.13 to 0.67]−1.5 [−2.58 to 1.32]−1.75 [−2.79 to 1.26]0.13Total hip BMD, g/cm20.927 (0.8 to 1.02)1.08 [1.02 to 1.13]0.94 [0.9 to 0.99]0.77 [0.73 to 0.82] < 0.0010.88 [0.79 to 0.98]0.88 [0.73 to 0.89]0.84 [0.71 to 0.93]0.149Total hip T-score, SD−1.24 (−2.2 to 0.43)−0.07 [−0.37 to 0.32]−1.19 [−1.44 to 0.6]−2.45 [−2.79 to 2.11] < 0.001−1.26 [−2.13 to 0.67]−1.5 [−2.58 to 1.32]−1.75 [−2.79 to 1.26]0.13TBS L1-L41.274 (1.18 to 1.35)1.32 [1.19 to 1.37]1.28 [1.18 to 1.35]1.25 [1.19 to 1.31]0.111.37 [1.35 to 1.44]1.28 [1.26 to 1.29]1.16 [1.13 to 1.21] < 0.001Quantitative variables are expressed as median (IQR) and qualitative variables as number (%).

Source: Participant characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted a cross-sectional study of 112 men (mean age 70.6 ± 7.98 years; range 50 to 83) with ileal UD.

Source: Abstract.

A total of 137 patients were initially screened.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Fracture risk assessment in patients with ileal urinary diversion after radical cystectomy: a comprehensive evaluation integrating bone mineral density, trabecular bone score, and FRAX®

Cross-sectional study · Archives of Osteoporosis · 2026

Original publication title

Fracture risk assessment in patients with ileal urinary diversion after radical cystectomy: a comprehensive evaluation integrating bone mineral density, trabecular bone score, and FRAX®

Arturo Domínguez; Enrique Casado; Jesús Muñoz-Rodríguez; Joan Prats; María Laura Grubicy; Núria Masip; Cristina Piqué; Clara Centeno; Teresa Bonfill; Diana Fuertes; Xavier Serra-Aracil

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Men with ileal UD showed reduced bone mass and a notable proportion of low TBS values, consistent with increased skeletal fragility and fracture risk. Structured bone health assessment should be considered during routine follow-up.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Patients undergoing radical cystectomy with UD face an increased risk of fracture; however, this aspect remains poorly investigated. We aimed to provide an integrated evaluation of skeletal health and fracture risk in men with UD.

Source: Purpose

Abstract: What methods does the paper describe?

We conducted a cross-sectional study of 112 men (mean age 70.6 ± 7.98 years; range 50 to 83) with ileal UD. BMD was measured using DXA, TBS was obtained from lumbar spine DXA images, and 10-year fracture risk was estimated using FRAX®. Logistic regression was used to identify predictors of osteoporosis and lower TBS values.

Source: Methods

Abstract: Summary

We conducted a comprehensive fracture risk assessment in 112 men with urinary diversion (UD) after radical cystectomy, integrating bone mineral density (BMD), trabecular bone score (TBS), and FRAX®. A substantial proportion met the diagnostic criteria for osteoporosis or had lower TBS values. These findings support routine skeletal assessment during follow-up.

Source: Summary

Abstract: Results

Osteoporosis was identified in 32.1% of patients, and 40.2% were classified in the lowest TBS category (TBS < 1.23). Only 12.5% had normal results for both BMD and TBS. Median FRAX-MOF was 3.9% (IQR 2.7 to 6.05) without BMD, 5.3% (2.98 to 7.82) with BMD, and 5.8% (3.4 to 9.5) when adjusted for TBS. Median FRAX-HIP was 1.35% (0.7 to 2.78), 1.8% (0.9 to 4.55) with BMD, and 2% (1 to 5.2) with TBS adjustment. Age (per year, OR = 1.11, 95% CI 1.02 to 1.20; p = 0.012) and BMI (per kg/m2, OR = 0.73, 95% CI 0.62 to 0.86; p < 0.001) were independently associated with osteoporosis, while serum creatinine (per mg/dL, OR = 2.11, 95% CI 1.08 to 4.11; p = 0.028), BMI (per kg/m2, OR = 0.91, 95% CI 0.83 to 0.99; p = 0.041), and prior fracture (OR = 5.23, 95% CI 2.08 to 13.13; p < 0.001) were associated with TBS < 1.23.

Metabolic acidosis was not associated with adverse skeletal outcomes or higher FRAX estimates.

Source: Results

Abstract: Conclusions

Men with ileal UD showed reduced bone mass and a notable proportion of low TBS values, consistent with increased skeletal fragility and fracture risk. Structured bone health assessment should be considered during routine follow-up.

Source: Conclusions
Authors’ abstract

Summary

We conducted a comprehensive fracture risk assessment in 112 men with urinary diversion (UD) after radical cystectomy, integrating bone mineral density (BMD), trabecular bone score (TBS), and FRAX®. A substantial proportion met the diagnostic criteria for osteoporosis or had lower TBS values. These findings support routine skeletal assessment during follow-up.

Purpose

Patients undergoing radical cystectomy with UD face an increased risk of fracture; however, this aspect remains poorly investigated. We aimed to provide an integrated evaluation of skeletal health and fracture risk in men with UD.

Methods

We conducted a cross-sectional study of 112 men (mean age 70.6 ± 7.98 years; range 50 to 83) with ileal UD. BMD was measured using DXA, TBS was obtained from lumbar spine DXA images, and 10-year fracture risk was estimated using FRAX®. Logistic regression was used to identify predictors of osteoporosis and lower TBS values.

Results

Osteoporosis was identified in 32.1% of patients, and 40.2% were classified in the lowest TBS category (TBS < 1.23). Only 12.5% had normal results for both BMD and TBS. Median FRAX-MOF was 3.9% (IQR 2.7 to 6.05) without BMD, 5.3% (2.98 to 7.82) with BMD, and 5.8% (3.4 to 9.5) when adjusted for TBS. Median FRAX-HIP was 1.35% (0.7 to 2.78), 1.8% (0.9 to 4.55) with BMD, and 2% (1 to 5.2) with TBS adjustment. Age (per year, OR = 1.11, 95% CI 1.02 to 1.20; p = 0.012) and BMI (per kg/m2, OR = 0.73, 95% CI 0.62 to 0.86; p < 0.001) were independently associated with osteoporosis, while serum creatinine (per mg/dL, OR = 2.11, 95% CI 1.08 to 4.11; p = 0.028), BMI (per kg/m2, OR = 0.91, 95% CI 0.83 to 0.99; p = 0.041), and prior fracture (OR = 5.23, 95% CI 2.08 to 13.13; p < 0.001) were associated with TBS < 1.23.

Metabolic acidosis was not associated with adverse skeletal outcomes or higher FRAX estimates.

Conclusions

Men with ileal UD showed reduced bone mass and a notable proportion of low TBS values, consistent with increased skeletal fragility and fracture risk. Structured bone health assessment should be considered during routine follow-up.

Supplementary Information

The online version contains supplementary material available at 10.1007/s11657-026-01685-x.

Publication and source details

Original title: Fracture risk assessment in patients with ileal urinary diversion after radical cystectomy: a comprehensive evaluation integrating bone mineral density, trabecular bone score, and FRAX®

Arturo Domínguez; Enrique Casado; Jesús Muñoz-Rodríguez; Joan Prats; María Laura Grubicy; Núria Masip; Cristina Piqué; Clara Centeno; Teresa Bonfill; Diana Fuertes; Xavier Serra-Aracil

Archives of Osteoporosis · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Fundació Institució dels Centres de Recerca de Catalunya (CERCA)

Open Access funding provided by CERCA through the CRUE-CSIC agreement with Springer Nature.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:45:57.871198+00:00

DOI: 10.1007/s11657-026-01685-x · PMC12979281